NeuroPace, Inc. (NPCE)
NASDAQ: NPCE · IEX Real-Time Price · USD
13.97
+0.98 (7.54%)
At close: May 1, 2024, 4:00 PM
14.21
+0.24 (1.72%)
After-hours: May 1, 2024, 4:15 PM EDT
NeuroPace Revenue
In the year 2023, NeuroPace had annual revenue of $65.42M with 43.72% growth. Revenue in the quarter ending December 31, 2023 was $18.01M with 40.84% year-over-year growth.
Revenue (ttm)
$65.42M
Revenue Growth
+43.72%
P/S Ratio
6.13
Revenue / Employee
$382,579
Employees
171
Market Cap
401.22M USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 65.42M | 19.90M | 43.72% |
Dec 31, 2022 | 45.52M | 337.00K | 0.75% |
Dec 31, 2021 | 45.18M | 4.05M | 9.83% |
Dec 31, 2020 | 41.14M | 4.17M | 11.27% |
Dec 31, 2019 | 36.97M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
OraSure Technologies | 405.47M |
Revance Therapeutics | 234.04M |
MaxCyte | 41.29M |
Mersana Therapeutics | 36.86M |
Cartesian Therapeutics | 26.00M |
Lexicon Pharmaceuticals | 1.20M |
NPCE News
- 14 days ago - NeuroPace to Report First Quarter 2024 Financial Results on May 8, 2024 - GlobeNewsWire
- 5 weeks ago - NeuroPace to Present at the Needham 23rd Annual Healthcare Conference - GlobeNewsWire
- 2 months ago - NeuroPace Announces Record Full Year 2023 Revenue of $65.4 Million - GlobeNewsWire
- 2 months ago - NeuroPace to Report Fourth Quarter and Full Year 2023 Financial Results on March 5, 2024 - GlobeNewsWire
- 4 months ago - NeuroPace Announces Preliminary Unaudited Revenue for Fourth Quarter and Full Year 2023 and Provides Business Updates - GlobeNewsWire
- 4 months ago - NeuroPace Announces Early Completion of Patient Enrollment in NAUTILUS Pivotal Study - GlobeNewsWire
- 4 months ago - NeuroPace to Present at the 42nd Annual J.P. Morgan Healthcare Conference - GlobeNewsWire
- 5 months ago - NeuroPace to Leverage the Power of its RNS System's Novel Data Collection, Brain Monitoring and Analysis Capabilities in Groundbreaking Collaboration - GlobeNewsWire